From Ideas to Innovation
We're excited to announce that From Ideas to Innovation will be back in 2026!
- Wednesday 15 and Thursday 16 April.
- 30 Euston Square, London, NW1 2FB.
What is From Ideas to Innovation?
Our biennial research conference - From Ideas to Innovation - brings prostate cancer researchers together to hear the latest research updates, network, develop collaborations, and hear inspiring stories from men living with prostate cancer.
Registration Open!
Register now to reserve your free place at From Ideas to Innovation. Places will be allocated on a first come, first served basis, with a final registration deadline of 15 January 2026, or earlier if the event becomes fully subscribed.
To ensure you don’t miss any updates on our upcoming research events, subscribe to the research newsletter and follow us on Bluesky or X (Twitter).
I loved to see that patients have been invited to share their stories. There was a wide range of topics and lots of time for networking. I found the whole atmosphere very friendly and I felt very welcomed.
A meeting for researchers designed by researchers
From Ideas to Innovation is co-designed with our fantastic Scientific Organising Committee to help ensure the event meets the research community's needs.
Day 1 Agenda: Wednesday 15 April 2026
Sessions and Speakers for Day 1 of From Ideas to Innovation.
We may update the agenda with minor changes, a final programme will be sent to delegates in advance of the event.
Registration will be held at 30 Euston Square, London, NW1 2FB, United Kingdom.
Refreshments and snacks will be provided.
Dr Matt Hobbs, Director of Research, Prostate Cancer UK .
Session Chair:
Dr Jane Shortall, University of Manchester.
Transformational Impact Award:
Targeting CXCR1 and CXCR2 blockade to maximise clearance of myeloid cells from advanced prostate cancer and reverse resistance to therapy.
Professor Johann de Bono, The Institute of Cancer Research.
Dr Alec Paschalis, The Institute of Cancer Research.
Research Snapshots:
Professor Johann de Bono, The Institute of Cancer Research.
Dr Pochuan Chiu, Imperial College London.
Dr Caroline Dalgliesh, Newcastle University.
Dr Ralf Zwacka, University of Essex.
Check back for more information on patient research partners, who will be added as they are confirmed.
Drinks and snacks will be provided.
Session Chair:
Dr Koichi Sasaki, Imperial College London.
Transformational Impact Award:
Leveraging Pan Prostate Cancer Group (PPCG) Resources for Predicting Prostate Cancer Outcome and to Facilitate Cancer Prevention.
Professor Colin Cooper, University of East Anglia.
Dr Harveer Dev, University of Cambridge.
Research Snapshots:
Professor Ananya Choudhury, University of Manchester.
Professor Aled Clayton, Cardiff University.
Dr Mark Linch, University College London.
Dr Demi Pritchard, Swansea University.
Dr Srinivasa Rao, University of Oxford.
Check back for more information on patient research partners, who will be added as they are confirmed.
Sandwiches , finger food and refreshments will be provided.
Poster presenters will be with their posters from 13:15.
Session Chair:
Dr Sarah Gosling, Keele University.
Major Award: A randomised controlled trial to assess screening for prostate cancer compared to current standard of care.
Professor Rakesh Heer, Imperial College London.
Professor Rhian Gabe, Queen Mary University of London.
Dr Nikhil Mayor, Imperial College London.
Check back for more information on patient research partners, who will be added as they are confirmed.
Session Chair:
Helen Eugene, Head of Equality, Diversity and Inclusion, Prostate Cancer UK.
Check back for more information which will be added as activities are confirmed.
Drinks and snacks will be provided.
Session Chair:
Dr Adriana Buskin, Newcastle University.
Transformational Impact Award:
A randomised controlled trial to assess the clinical and cost-effectiveness of PSMA PET imaging to stage newly diagnosed high risk prostate cancer.
Professor Hashim Ahmed, Imperial College London.
Dr Martin Connor, Imperial College London.
Research Snapshots:
Professor Anne Kiltie, University of Aberdeen.
Dr Brianna Nevin, Queen's University Belfast.
Dr Boris Tocco, Kings College London.
Dr Zhuolin Yang, University of Edinburgh.
Check back for more information on patient research partners who will be added as they are confirmed.
Networking opportunity.
Day 2 Agenda: Thursday 16 April 2026
Sessions and Speakers for Day 2 of From Ideas to Innovation.
We may update the agenda with minor changes, a final programme will be sent to delegates in advance of the event.
Networking opportunity.
Dr Matt Hobbs, Director of Research, Prostate Cancer UK .
Session Chair:
Dr Rayzel Fernandes, Imperial College London.
Transformational Impact Award:
Investigating the tumour microenvironment of high-risk localised prostate cancer to identify actionable pathways involved in cancer.
Professor Hing Leung, University of Glasgow & CRUK Scotland Institute.
Dr Ed Roberts, University of Glasgow & CRUK Scotland Institute.
Research Snapshots:
Dr Natalie Bevan, Queen Mary University of London.
Dr Damien Leach, Imperial College London.
Dr Helen Pearson, Cardiff University.
Dr Nina Tunariu, The Institute of Cancer Research.
Check back for more information on patient research partners who will be added as they are confirmed.
Drinks and snacks will be provided.
Session Chair:
Dr Corinne Woodcock, University of Nottingham.
Transformational Impact Award:
Understanding the Abscopal effect in Prostate Cancer – Primary and Metastatic Tumour Crosstalk.
Professor Charlotte Bevan, Imperial College London.
Early Career Researcher (TBC), Imperial College London.
Research Snapshots:
Dr Eleanor Bellow, University of Nottingham.
Dr Marco Bezzi, The Institute of Cancer Research.
Jess Peng, Newcastle University.
Dr Gareth Richards, University of Sheffield.
Check back for more information on patient research partners who will be added as they are confirmed.
Sandwiches, finger food and refreshments will be provided.
Poster presenters will be with their posters from 13:15.
Simon Grieveson, Assistant Director of Research, Prostate Cancer UK
Dr Hayley Luxton, Head of Research Impact and Engagement, Prostate Cancer UK.
Session Chair:
Dr Ahmet Hazini, University of Oxford.
Transformational Impact Award:
STOPCAP 2 - Maximising patient benefit through enhanced evaluation of therapies and better characterisation of metastatic hormone-sensitive prostate cancer.
Professor Jayne Tierney, University College London.
Dr Hannah Rush, University College London.
Dr Annabelle South, University College London.
Research Snapshots:
Cameron Alexander, University of Manchester.
Dr Kelly Coffey, Newcastle University.
Dr Chun Fui Lai, Imperial College London.
Dr Melissa LaBonte Wilson, Queen's University Belfast.
Check back for more information on patient research partners who will be added as they are confirmed.
Drinks and snacks will be provided.
Session Chair:
Dr Emma Lishman-Walker, Newcastle University.
Transformational Impact Award:
STAMPEDE Life: Temporal-spatial resolution of prostate cancer evolution to a lethal hormone and radioligand therapy resistant phenotype in metastatic patients randomised in the STAMPEDE2 trial.
Professor Gert Attard, University College London.
Dr Ashwin Sachdeva, University of Manchester.
Dr Emily Grist, University College London.
Research Snapshots:
Professor Ian Mills, University of Oxford.
Professor Francesco Crea, Open University.
Dr James Hindley, Kings College London.
Dr Nicola Annels, University of Surrey.
Check back for more information on patient research partners, who will be added as they are confirmed.
Laura Kerby: CEO, Prostate Cancer UK.
Frequently Asked Questions
Who can attend From Ideas to Innovation?
Any researcher, from any stage of their career is welcome to attend. You don't have to be funded by Prostate Cancer UK.
Can I present my work?
We've been delighted by the strong interest in presenting posters at the event, and all presentation slots are now filled. If you've already indicated via the registration form that you'd like to present a poster, we'll get in touch later in the year with more details.
Speakers at Ideas to Innovation are by invitation. If you're an early career researcher, you'll be able to apply for a speaking slot at the next Making Progress event.
Is there a registration fee?
Prostate Cancer UK is covering the costs of running the event to keep the event free for researchers.
Will you cover travel costs for presenters?
We're able to cover reasonable travel costs for invited speakers. We'll give you more information on booking travel in early 2026.
Will you cover travel costs for attendees?
You may be able to cover travel costs from your Prostate Cancer UK grant budget. Check with the grant holder if conference costs were included in the award and confirm with them if there is money available in the conference budget for your 'From Ideas to Innovation' travel costs. Please then email [email protected], copying in the grant holder and quoting the grant reference, and we’ll confirm whether the costs can be charged. We’re sorry, but you won't be able to claim the travel costs of team members who are not directly employed on the grant.
Please register early and book any travel and accommodation as soon as possible to take advantage of lower prices.
If the cost of travel prevents you from attending From Ideas to Innovation, there will be a limited number of travel bursaries available.
- You may be able to cover travel costs from your Prostate Cancer UK grant budget. Before applying for a bursary, please check with the grant holder if conference costs were included in the award and confirm with them if there is money available in the conference budget for your 'From Ideas to Innovation' travel costs. Please then email [email protected], copying in the grant holder and quoting the grant reference, and we’ll confirm whether the costs can be charged. We’re sorry, but you won't be able to claim the travel costs of team members who are not directly employed on the grant.
- Before applying for a bursary, researchers must seek funding for travel costs from their own institution and should only apply for the bursary if they have exhausted all other funding options. We’ll require proof that funds are not available elsewhere as part of the application e.g. an email from your principal investigator / institution.
- If a travel bursary is awarded, Prostate Cancer UK will book suitable travel in liaison with the researcher. There will be no transfer of money to the researcher.
- So that we can support as many researchers as possible, we’ll book the most economic form and times of travel e.g. making bookings as soon as train tickets become available and avoiding rush hour prices. We won’t be able to reimburse driving costs.
- It’s unlikely that we’ll be able to fund applicants who are travelling from the London area, and priority will be given to applicants who will be travelling for more than an hour.
- We’re not able to cover accommodation costs at this time.
- Applications will be considered on a first come first served basis. We aim to let you know the outcome of your application within approximately two weeks. We have limited funds available and once these funds are allocated, the bursary will close for applications.
To be considered for a travel bursary, please submit this application form. If you have any questions, please contact [email protected]
